Cargando…

Evaluation of a species-specific C-reactive protein assay for the dog on the ABX Pentra 400 clinical chemistry analyzer

BACKGROUND: A canine-specific immunoturbidimetric CRP assay, Gentian Canine CRP Immunoassay) with species-specific controls and calibrators was introduced and recently evaluated on the clinical chemistry analyzer Abbott Architect c4000 as well as on the Olympus AU600. Aims of our study were 1) to in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hindenberg, Sarah, Klenner-Gastreich, Stefanie, Kneier, Nicole, Zielinsky, Sabine, Gommeren, Kris, Bauer, Natali, Moritz, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450169/
https://www.ncbi.nlm.nih.gov/pubmed/28558755
http://dx.doi.org/10.1186/s12917-017-1065-9
_version_ 1783239911079411712
author Hindenberg, Sarah
Klenner-Gastreich, Stefanie
Kneier, Nicole
Zielinsky, Sabine
Gommeren, Kris
Bauer, Natali
Moritz, Andreas
author_facet Hindenberg, Sarah
Klenner-Gastreich, Stefanie
Kneier, Nicole
Zielinsky, Sabine
Gommeren, Kris
Bauer, Natali
Moritz, Andreas
author_sort Hindenberg, Sarah
collection PubMed
description BACKGROUND: A canine-specific immunoturbidimetric CRP assay, Gentian Canine CRP Immunoassay) with species-specific controls and calibrators was introduced and recently evaluated on the clinical chemistry analyzer Abbott Architect c4000 as well as on the Olympus AU600. Aims of our study were 1) to independently evaluate the canine-specific CRP assay on the ABX Pentra 400 clinical chemistry analyzer in comparison to the previously validated human-based immunoturbidimetric assay (Randox Canine CRP assay) and 2) to assess the impact of different sample types (serum versus heparinized plasma) on the results. Imprecision, accuracy, interference and the prozone effect were determined using samples from healthy and diseased dogs (n = 278). The Randox Canine CRP assay calibrated with canine specific control calibration material served as a reference method. Additionally, the impact of the sample type (serum and lithium heparin) was evaluated based on samples of healthy and diseased dogs (n = 49) in a second part of the study. RESULTS: Linearity was present for CRP concentrations ranging from 4 to 281 mg/l. For clinically relevant CRP concentrations of 7–281 mg/l, recovery ranged between 90 and 105% and intra- and inter-assay CVs ranged between 0.68% - 12.12% and 0.88% - 7.84%, respectively. CV was thus lower than 12.16%, i.e. the desired CV% based on biological variation. Interference was not present up to a concentration of 5 g/l hemoglobin, 800 mg/l bilirubin and 10 g/l triglycerides. No prozone effect occurred up to 676 mg/l CRP. Method comparison study revealed a Spearman’s rank correlation coefficient of r(s) = 0.98 and a mean constant bias of 5.2%. The sample type had a significant (P = 0.008) but clinically not relevant impact on the results (median CRP of 30.9 mg/l in lithium heparin plasma versus 31.4 mg/l in serum). CONCLUSIONS: The species-specific Gentian Canine CRP Immunoassay reliably detects canine CRP on the ABX Pentra 400 clinical chemistry analyzer whereby both serum and heparin plasma can be used. The quality criteria reached on the Abbott Architect c4000 and Olympus AU600 could be met.
format Online
Article
Text
id pubmed-5450169
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54501692017-06-01 Evaluation of a species-specific C-reactive protein assay for the dog on the ABX Pentra 400 clinical chemistry analyzer Hindenberg, Sarah Klenner-Gastreich, Stefanie Kneier, Nicole Zielinsky, Sabine Gommeren, Kris Bauer, Natali Moritz, Andreas BMC Vet Res Research Article BACKGROUND: A canine-specific immunoturbidimetric CRP assay, Gentian Canine CRP Immunoassay) with species-specific controls and calibrators was introduced and recently evaluated on the clinical chemistry analyzer Abbott Architect c4000 as well as on the Olympus AU600. Aims of our study were 1) to independently evaluate the canine-specific CRP assay on the ABX Pentra 400 clinical chemistry analyzer in comparison to the previously validated human-based immunoturbidimetric assay (Randox Canine CRP assay) and 2) to assess the impact of different sample types (serum versus heparinized plasma) on the results. Imprecision, accuracy, interference and the prozone effect were determined using samples from healthy and diseased dogs (n = 278). The Randox Canine CRP assay calibrated with canine specific control calibration material served as a reference method. Additionally, the impact of the sample type (serum and lithium heparin) was evaluated based on samples of healthy and diseased dogs (n = 49) in a second part of the study. RESULTS: Linearity was present for CRP concentrations ranging from 4 to 281 mg/l. For clinically relevant CRP concentrations of 7–281 mg/l, recovery ranged between 90 and 105% and intra- and inter-assay CVs ranged between 0.68% - 12.12% and 0.88% - 7.84%, respectively. CV was thus lower than 12.16%, i.e. the desired CV% based on biological variation. Interference was not present up to a concentration of 5 g/l hemoglobin, 800 mg/l bilirubin and 10 g/l triglycerides. No prozone effect occurred up to 676 mg/l CRP. Method comparison study revealed a Spearman’s rank correlation coefficient of r(s) = 0.98 and a mean constant bias of 5.2%. The sample type had a significant (P = 0.008) but clinically not relevant impact on the results (median CRP of 30.9 mg/l in lithium heparin plasma versus 31.4 mg/l in serum). CONCLUSIONS: The species-specific Gentian Canine CRP Immunoassay reliably detects canine CRP on the ABX Pentra 400 clinical chemistry analyzer whereby both serum and heparin plasma can be used. The quality criteria reached on the Abbott Architect c4000 and Olympus AU600 could be met. BioMed Central 2017-05-30 /pmc/articles/PMC5450169/ /pubmed/28558755 http://dx.doi.org/10.1186/s12917-017-1065-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Hindenberg, Sarah
Klenner-Gastreich, Stefanie
Kneier, Nicole
Zielinsky, Sabine
Gommeren, Kris
Bauer, Natali
Moritz, Andreas
Evaluation of a species-specific C-reactive protein assay for the dog on the ABX Pentra 400 clinical chemistry analyzer
title Evaluation of a species-specific C-reactive protein assay for the dog on the ABX Pentra 400 clinical chemistry analyzer
title_full Evaluation of a species-specific C-reactive protein assay for the dog on the ABX Pentra 400 clinical chemistry analyzer
title_fullStr Evaluation of a species-specific C-reactive protein assay for the dog on the ABX Pentra 400 clinical chemistry analyzer
title_full_unstemmed Evaluation of a species-specific C-reactive protein assay for the dog on the ABX Pentra 400 clinical chemistry analyzer
title_short Evaluation of a species-specific C-reactive protein assay for the dog on the ABX Pentra 400 clinical chemistry analyzer
title_sort evaluation of a species-specific c-reactive protein assay for the dog on the abx pentra 400 clinical chemistry analyzer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450169/
https://www.ncbi.nlm.nih.gov/pubmed/28558755
http://dx.doi.org/10.1186/s12917-017-1065-9
work_keys_str_mv AT hindenbergsarah evaluationofaspeciesspecificcreactiveproteinassayforthedogontheabxpentra400clinicalchemistryanalyzer
AT klennergastreichstefanie evaluationofaspeciesspecificcreactiveproteinassayforthedogontheabxpentra400clinicalchemistryanalyzer
AT kneiernicole evaluationofaspeciesspecificcreactiveproteinassayforthedogontheabxpentra400clinicalchemistryanalyzer
AT zielinskysabine evaluationofaspeciesspecificcreactiveproteinassayforthedogontheabxpentra400clinicalchemistryanalyzer
AT gommerenkris evaluationofaspeciesspecificcreactiveproteinassayforthedogontheabxpentra400clinicalchemistryanalyzer
AT bauernatali evaluationofaspeciesspecificcreactiveproteinassayforthedogontheabxpentra400clinicalchemistryanalyzer
AT moritzandreas evaluationofaspeciesspecificcreactiveproteinassayforthedogontheabxpentra400clinicalchemistryanalyzer